What: Researchers have identified potential biomarkers that could alert clinicians to which new mothers are at higher risk for postpartum depression.
Key line: [Details not provided].
Source: Weill Cornell Medicine.
A study underscores that preventing preeclampsia is key to reducing serious postpartum complications.
A study from the University of Washington finds significant racial and socioeconomic disparities in accessing same-day diagnostic services after an abnormal mammogram.
The New York Times investigates whether testosterone therapy could benefit menopausal women.
RFK Jr. demonstrated uncertainty over Medicare fundamentals during his nomination hearing.
Chiquita Brooks-LaSure warns that cuts by Elon Musk’s DOGE team could jeopardize health insurance coverage for many American women, affecting both Medicaid and Medicare.
A study found the Oura ring can pinpoint menstrual cycles with 96.4% accuracy.
The debate over rebranding early-stage cancers like DCIS aims to reduce patient anxiety.
A retrospective study found that preconception use of GLP-1 medications was associated with reduced risks of several adverse pregnancy outcomes.
A New York physician faces indictment in Louisiana for prescribing abortion pills.
A federal judge temporarily halted Trump’s planned deep NIH funding cuts after attorneys general from 22 states sued to block the move.
An intimate essay describes the overwhelming stress of a high-risk pregnancy designation.
A new study suggests a blood test might help predict postpartum depression risk.
Oregon lawmaker Shelly Boshart Davis recounts her personal experience of being denied menopause care and advocates for insurer coverage of hormone therapy.
Halle Berry speaks with Time about her plans to push for improved menopause treatment and increased emphasis on menopause education in medical schools.
Research shows the causes of maternal mortality differ widely from state to state.
Vox examines strategies that might let Trump maintain a moderate image on abortion while enforcing restrictions.
The Trump IVF Executive Order does not make IVF free but instead asks for policy recommendations to lower costs, marking an initial step.
A study comparing sisters of women with and without pregnancy complications found that genetic and environmental factors may drive cardiovascular disease risk.
A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.
The Trump administration’s removal of CDC pages is disrupting detailed contraceptive guidelines.